HIE - Hypoxic - Ischemic Encephalopathy: Clinical Trials

2 trials for HIE - Hypoxic - Ischemic Encephalopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 2
Phase 21Not yet recruiting 1

Follow HIE - Hypoxic - Ischemic Encephalopathy: new trials by email Literature Review of HIE - Hypoxic - Ischemic Encephalopathy trials Research Report on HIE - Hypoxic - Ischemic Encephalopathy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy
MSC, marrow, Placebo - Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia
Phase 2 / Phase 3Not yet recruitingUMC Utrecht1622027-04-012026-09-21
COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHLOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE
MgSO4 (seizure prevention), Melatonin , Mgso4 - HIE - Hypoxic - Ischemic Encephalopathy
Phase 3Not yet recruitingUniversity of Child Health Sciences and Children's Hospital, Lahore802026-07-012026-06-17

Narrower conditions

Hypoxia-Ischemia, Brain (1)

Broader conditions

Brain Diseases (1)  ·  Brain Ischemia (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Hypoxia (1)  ·  Hypoxia, Brain (1)  ·  Nervous System Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)  ·  Vascular Diseases (1)

Interventions

Magnesium Sulfate (1)  ·  Melatonin (1)

Sponsors

UMC Utrecht (1)  ·  University of Child Health Sciences and Children's Hospital, Lahore (1)

NIH funding

2025 (1)